FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 63 filers reported holding FOGHORN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11 | -31.2% | 1,871 | -22.7% | 0.00% | – |
| Q1 2024 | $16 | +33.3% | 2,422 | +28.7% | 0.00% | – |
| Q4 2023 | $12 | +20.0% | 1,882 | -1.7% | 0.00% | – |
| Q3 2023 | $10 | -23.1% | 1,914 | +4.0% | 0.00% | – |
| Q2 2023 | $13 | -84.7% | 1,841 | -86.5% | 0.00% | – |
| Q1 2023 | $85 | -2.3% | 13,686 | 0.0% | 0.00% | – |
| Q4 2022 | $87 | -99.9% | 13,686 | +0.0% | 0.00% | – |
| Q3 2022 | $117,000 | -37.1% | 13,683 | +0.3% | 0.00% | – |
| Q2 2022 | $186,000 | -10.6% | 13,641 | -0.2% | 0.00% | – |
| Q1 2022 | $208,000 | -33.3% | 13,673 | +0.1% | 0.00% | – |
| Q4 2021 | $312,000 | +63.4% | 13,655 | -0.3% | 0.00% | – |
| Q3 2021 | $191,000 | +6.7% | 13,701 | -18.2% | 0.00% | – |
| Q2 2021 | $179,000 | +231.5% | 16,758 | +308.7% | 0.00% | – |
| Q1 2021 | $54,000 | -34.9% | 4,100 | 0.0% | 0.00% | – |
| Q4 2020 | $83,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $10,822,000 | 10.05% |
| Flagship Pioneering Inc. | 12,674,120 | $108,744,000 | 4.58% |
| Birchview Capital, LP | 264,843 | $2,272,000 | 1.60% |
| Artal Group S.A. | 1,720,720 | $14,764,000 | 0.63% |
| Rockwood Wealth Management, LLC | 124,030 | $1,064,178 | 0.34% |
| Alphabet Inc. | 500,901 | $4,298,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $6,671,000 | 0.13% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 330,051 | $2,832,000 | 0.04% |
| Virtus ETF Advisers LLC | 8,258 | $71,000 | 0.03% |
| Point72 Asset Management, L.P. | 388,600 | $3,334,000 | 0.01% |